Article
Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapy
2026-06-14
Abstract excerpt
<title>Abstract</title> <p> Background Peptide receptor radionuclide therapy with [ <sup>177</sup> Lu]Lu-DOTATATE is an established treatment for somatostatin receptor–expressing neuroendocrine tumors. Although strong anti-tumor effects have been demonstrated in experimental models, curative responses in patients remain limited. Improved understanding of the molecular responses induced by [ <sup>177</sup> L...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced Proteomics Techniques and Applications
- Cancer Research and Treatments
- Lung Cancer Research Studies
- Medical Imaging Techniques and Applications
- Neuroblastoma Research and Treatments
- Neuroendocrine Tumor Research Advances
- Radiopharmaceutical Chemistry and Applications
- Thyroid Disorders and Treatments
Identifiers and source
- Literature Corpus work
- 0259ed0a-5a7e-51b4-aa3e-b60da777e2ca
- DOI
- 10.21203/rs.3.rs-9833935/v1
